Safety and effectiveness of empagliflozin in Japanese patients with heart failure: a 1-year post-marketing surveillance study stratified by age.

Summary: A new study looked at a heart medicine called empagliflozin. Doctors gave it to over 1,000 older patients in Japan who have heart failure. They watched these patients for one year to see if the medicine was safe and if it helped them stay out of the hospital. The results showed that the medicine was very safe and easy for most patients to take. This is great news for people who need a reliable treatment for a weak heart.